BUSINESS
Pfizer to shutdown Chennai, Aurangabad plants, may impact 1700 employees
Both plants came under Pfizer's ownership after it acquired Hospira in the US.
BUSINESS
Lawmakers urge govt action against J&J in faulty hip implant case
There are currently no specific legal provisions to provide compensation to patients.
BUSINESS
The Bedaquiline conundrum: Why this TB drug is creating an intense debate
Bedaquiline, developed by Johnson & Johnson (J&J), is used for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB)
BUSINESS
Valsartan recalls raise blood pressure of Indian drug makers
So far US FDA inspectors believe contaminated compounds were unintentionally created through a chemical reaction.
ECONOMY
Ayushman Bharat's implementing agency gets full autonomy
“The National Health Authority shall have full autonomy, accountability and the mandate to implement PM-JAY through an efficient, effective and transparent decision-making process,” the government said in statement.
BUSINESS
NBFC sector remains fragile, but seeing signs of recovery: Uday Kotak
"The NBFC sector, which saw significant pressure in October-November, is beginning to breathe a little better," he said in an annual message to employees of Kotak Mahindra Bank.
BUSINESS
100 days of Ayushman Bharat: 6.85 lakh patients availed free treatment, 5,000 claims handled daily
So far 6.85 lakh patients have been provided free hospital treatment under the scheme. Around 5.1 lakh claims have been availed of the scheme, for which payment has been released.
BUSINESS
Govt sets up council to boost local manufacturing, export of medical devices
The Council will be headed by Secretary, DIPP of the Ministry of Commerce and Industry
BUSINESS
Top five discoveries in 2018 that can solve unmet medical needs
For those suffering from diabetes, pricking fingers may become a thing of the past very soon.
BUSINESS
A look at how Cipla is trying to consolidate its position in respiratory segment
Cipla sells a range of products including pills, nasal sprays and inhalers to treat respiratory diseases.
BUSINESS
Rising shipments to US help Indian pharma exports rebound in H1FY19
In the first half of FY19, shipments to US rose 10.34 percent to $3.2 billion, while exports to other countries grew 13 percent to $7.6 billion.
BUSINESS
Major factors that moved the pharma and healthcare industries in 2018; what to expect in 2019
The sectors didn't bring much cheer to investors and the S&P BSE Healthcare index that represents pharma and healthcare stocks underperformed compared to the benchmark Sensex.
BUSINESS
Operational, regulatory challenges hasten consolidation in Indian private hospital sector
Analysts tracking the sector say hospital businesses have been witnessing deterioration since the beginning of 2017.
BUSINESS
Max India to sell stake in Max Healthcare to Radiant, KKR
The deal includes Radiant Life's purchase of a 49.7 percent stake in Max Healthcare from South Africa-based hospital operator Life Healthcare International Proprietary.
BUSINESS
Lupin out-licenses novel blood cancer drug to AbbVie
Under the terms of the agreement, AbbVie will pay Lupin an upfront payment of $30 million for an exclusive license to the program.
BUSINESS
Biocon-Mylan faces competition in US for trastuzumab from Teva-Celltrion duo
It's not just Mylan-Biocon and Celltrion-Teva, other rival drug makers such as Samsung Bioepis, Pfizer and Amgen have all coming-up with their trastuzumab versions, indicating intensified competition for the drug that raked in about $7.55 billion of sales in 2017.
BUSINESS
Merger of GSK-Pfizer consumer businesses may not have much impact in India
At least three popular brands of Pfizer in India, Corex, Gelusil, Becosules will be not be marketed under that JV. Those three key brands constitute about one-fifth of Pfizer's sales in India.
BUSINESS
How Baba Ramdev's Patanjali pulled this company from the brink
As JHS Svendgaard was trying to claw its way back, it got a huge boost in the form of Patanjali's Ayurvedic toothpaste Dant Kanti.
BUSINESS
IHH puts Fortis open offer on hold, says seeking legal advice on SC's order
The proposed open offer is scheduled to be launched from December 18 to January 1, 2019.
BUSINESS
Delhi High Court quashes Centre's ban on Oxytocin manufacture and sale
The court held that the Central government failed to balance the interests of pregnant women, the right of the private companies to carry on their business and the misuse of the drug in the field of veterinary science.
BUSINESS
Ambulance operator Ziqitza Healthcare plans to raise $40 million from PE investors
The company said it is in talks with investors from India and abroad, and is looking to close the deal by April 2019.
BUSINESS
Will uphold autonomy and integrity of RBI, says new governor Shaktikanta Das
Das in his brief maiden press conference on December 12 sounded conciliatory calling for stakeholder consultation. He tried to allay concerns related to RBI's autonomy.
BUSINESS
JHS Svendgaard eyes manufacturing unit in south India for personal care foray
Nanda said the acquisition would cost around Rs 40-50 crore and the company may have to raise funds
BUSINESS
Corporate India surprised and worried as RBI governor Urjit Patel steps down
Corproate executives and economists that Moneycontrol spoke to expressed concerns of instability at the RBI and the impact it will have on attracting long-term investments.
